Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 1 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 2 Country / region: Canada Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20061
20083
20092
20103
20112
20123
20135
20146
20153
20166
20171
20182
20192
20211
20221
20234
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Withdrawn5
Active, not recruiting3
Recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Cliniques de Montreal16
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)10
University of Alberta4
Boehringer Ingelheim2
Jaeb Center for Health Research2
McGill University2
National Institute of Allergy and Infectious Diseases (NIAID)2
Novo Nordisk A/S2
Sanofi2
Anelixis Therapeutics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 156
Hypoglycemia19
Insulin Resistance16
Diabetes Mellitus7
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Autoimmune Diseases1
Cardiovascular Diseases1
Endocrine System Diseases1
Glucose Intolerance1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.